Simvastatin이 골결손부 회복에 미치는 영향 = Effect of Simvastatin collagen graft on wound healing of defective bone

다국어 초록 (Multilingual Abstract)

Purpose : To observe and evaluate the effects of Simvastatin-induced osteogenesis on the wound healing of defective bone.
Materials and Methods : 64 defective bones were created in the parietal bone of 32 New Zealand White rabbits. The defects were grafted with collagen matrix carriers mixed with Simvastatin solution in the experimental group of 16 rabbits and with collagen matrix carriers mixed with water in the controlled group. The rabbits were terminated at an interval of 3, 5, 7, and 9 days, 2, 4, 6, and 8 weeks after the formation of defective bone. The wound healing was evaluated by soft X-ray radiography. The tissues within defective bones were evaluated through the analysis of flow cytometry for the manifestation of Runx2 and Osteocalcin, and observed histopathologically by using H-E stain and Masson’s trichrome stain.
Results : 1. In the experimental group, flow cytometry revealed more manifestation of Runx2 at 5, 7, and 9 days and Osteocalcin at 2 weeks than in the controlled groups, but there was few difference in comparison with the controlled group.
2. In the experimental group, flow cytometry revealed considerably more cells and erythrocytes at 5, 7, and 9 days in comparison with the controlled group.
3. In the experimental group, soft x-ray radiography revealed the extended formation of trabeculation at 2, 4, 6, and 8 weeks.
4. Histopathological features of the experimental group showed more fibroblasts and newly formed vessels at 5 and 7 days, and the formation of osteoid tissues at 9 days, and the newly formed trabeculations at 4 and 6 weeks.
Conclusion : As the induced osteogenesis by Simvastatin, there was few contrast of the manifestation between Runx2 and Osteocalcin based on the differentiation of osteoblasts. But it was considered that the more formation of cells and erythrocytes depending on newly formed vessels in the experimental group obviously had an effect on the bone regeneration.

참고문헌 (Reference)

1 Urist MR, "β-tricalcium phosphate delivery system for bone morphogenetic protein" 187 : 227-280, 1984

2 Celeste AJ, "factor beta family members present in bone-inductive protein purified from bovine bone" 87 : 9843-9847, 1990

3 Watanabe S, "effects of 1-year treatment with fluvastatin or pravastatin on bone" 110 : 584-587, 2001

4 Wong RWK, "collagen grafts used to repair defects in the parietal bone of rabbits" 41 : 244-248, 2003

5 Mundy GR, "Vision for the future in osteoporosis research" 2 : 29-34, 1993

6 Yancopoulos G, "Vascular-specific growth factors and blood vessel formation" 407 : 242-252, 2000

7 Bates D, "Vascular endothelial growth factor and microvascular permeability" 6 : 83-89, 1999

8 Rabie ABM, "VEGF and bone formation in the glenoid fossa during forward mandibular positioning" 122 : 202-209, 2002

9 Altkorn D, "Treatment of postmenopausal osteoporosis" 258 : 1415-1418, 2001

10 Nakase T, "Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing" 9 : 651-659, 1994

11 King GN, "The effect of root surface demineralization on bone morphogenetic protein-2-induced healing of rat periodontal fenestration defects" 69 : 561-570, 1998

12 Schmitz JP, "The critical size defects as an experimental model for craniomandibular nonunions" 205 : 299-308, 1985

13 Mundy G, "Stimulation of bone formation in vitro and in rodents by statins" 286 : 1946-1949, 1999

14 Mundy G, "Statins and their potential for osteoporosis" 29 : 495-497, 2001

15 LaCroix A, "Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women’s Health Initiative Observational Study" 139 : 97-104, 2003

16 Urist MR, "Solubilized and insolubilized bone morphogenetic protein (cell differentiation/osteogenesis/ noncollagenous protein)" 76 : 1828-1832, 1979

17 Wahner HW, "Single- and dual-photon absorptiometry in osteoporosis and osteo malacia" 17 : 305-315, 1987

18 Tsuru S, "Separation of osteoblast-like cells from bone marrow by fluorescenceactivated cell sorting" 32 : 43-48, 1984

19 Wang EA, "Recombinant human bone morphogenetic protein induces bone formation (cartilage induction)" 87 : 2220-2224, 1990

20 Wasserman SNS, "Osteoporosis; the state of the art in 1987: a review" 17 : 283-292, 1987

21 Kenny AM, "Osteoporosis; pathogenesis, diagnosis and treatment in older adult" 26 : 569-591, 2000

22 Chen JL, "Osteoblast precursor cells are found in CD34+ cells from human bone marrow" 15 : 367-377, 1997

23 Wozney JM, "Novel regulators of bone formation; molecular clones and activities" 242 : 1528-1534, 1988

24 Schortinghuis J, "Microradiography to evaluate bone growth into a rat mandibular defect" 48 : 155-160, 2003

25 Matsumoto F, "Light- and electronmicroscopic observation on the mandibular condylar cartilage in growing rats on a low-calcium diet" 142 : 41-48, 1991

26 Zellin G, "Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects" 35 : 181-190, 1997

27 Lindholm TS, "Histological components of tibial fracture callus in growing osteopenic rats" 449 : 7-18, 1975

28 Meier C, "HMG-CoA reductase inhibitors and the risk of fractures" 283 : 3205-3210, 2000

29 Smith N, "Extraction socket healing in the calcium deficient rat" 20 : 22-26, 1975

30 Suzawa M, "Extracellular matrix associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro" 140 : 2125-2133, 1999

31 Deckers MM, "Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation" 141 : 1667-1674, 2000

32 King GN, "Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo" 33 : 226-236, 1998

33 Maritz F, "Effect of statins on bone mineral density and bone histomorphometry in rodents" 21 : 1636-1641, 2001

34 Rasmussen P, "Effect of extreme calcium deprivation on degree of mineralization of alveolar bone, dentin and enamel in rat" 80 : 327-333, 1972

35 Vita JA, "Effect of cholesterol-lowering therapy on coronary endothe-lial vasomotor function in patients with coronary artery disease" 102 : 846-851, 2000

36 Wong RW, "Early healing pattern of statin-induced osteogenesis" 43 : 46-50, 2005

37 Haddad AJ, "Closure of rabbit calvarial critical-sized defects using protective composite allogeneic and alloplastic bone substitutes" 17 : 926-934, 2006

38 Clokie CM, "Closure of critical sized defects with allogenic and alloplastic bone substitutes" 13 : 111-121, 2002

39 Johnston Jr CC, "Clinical, biochemical, radiographic, epidermiologic and economic features of osteoporosis" 12 : 559-569, 1981

40 Kawamura M, "Chondrogenetic Response to crude bone matrix protein bond to hydroxyapatite" 217 : 281-292, 1987

41 Ferguson D, "Bovine bone morphogenetic protein (bBMP) fraction induced repair of craniotomy defect in rhesus monkey" 219 : 251-258, 1987

42 Urist MR, "Bone: formation by autoinduction" 150 : 893-899, 1965

43 Higuchi T, "Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling" 70 : 1026-1031, 1999

44 Urist MR, "Bone morphogentic protein" 50 : 1392-1406, 1971

45 Wozney JM, "Bone morphogenetic proteins and their gene expression. In Cellular and Molecular Biology of Bone" Academic press 132-169, 1993

46 Wozney JM, "Bone morphogenetic proteins" 1 : 267-280, 1989

47 Wang EA, "Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells" 9 : 57-71, 1993

48 Whitney C, "Are cardiovascular disease and osteoporosis directly linked" 34 : 779-807, 2004

49 LinksShand JM, "Allogeneic bone grafting of calvarial defects: an experimental study in the rabbit" 31 : 525-531, 2002

50 Howell TH, "A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation" 17 : 11-25, 1997